Maravai LifeSciences
Maravai LifeSciences, a leading provider in the research and development services sector, is headquartered in the United States. Founded in 2016, the company has rapidly established itself as a key player in the life sciences industry, focusing on essential areas such as nucleic acid production, biopharmaceutical development, and diagnostic solutions.
With a commitment to innovation, Maravai offers unique core products and services, including high-quality plasmid DNA and RNA synthesis, which are critical for advancing therapeutic and diagnostic applications. The company has achieved significant milestones, positioning itself as a trusted partner for researchers and developers globally. Maravai LifeSciences continues to enhance its market presence through strategic growth and a dedication to scientific excellence.
-6 vs industry average
Maravai LifeSciences’s score of 23 is lower than 44% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Maravai LifeSciences?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Maravai LifeSciences's reported carbon emissions
Maravai LifeSciences, a US-based research and development services firm, has reported its carbon emissions for recent years. In 2024, the company's total emissions were approximately 9.7 million kg CO2e. This figure comprises Scope 1 emissions of about 862,580 kg CO2e, Scope 2 emissions of approximately 2.2 million kg CO2e (market-based), and Scope 3 emissions reaching about 6.6 million kg CO2e. For 2023, total emissions stood at approximately 13.0 million kg CO2e, with Scope 1 at around 736,590 kg CO2e, Scope 2 at approximately 2.0 million kg CO2e (market-based), and Scope 3 at roughly 10.0 million kg CO2e. Previously, for 2022, Maravai LifeSciences disclosed Scope 1 emissions of about 377,000 kg CO2e and Scope 2 emissions of approximately 1.3 million kg CO2e (market-based). Scope 3 emissions data for 2022 were not provided. In 2021, Scope 1 emissions were around 330,000 kg CO2e, and Scope 2 emissions were approximately 1.1 million kg CO2e (market-based), with Scope 3 data also not available for that year. Maravai LifeSciences is committed to climate action, as indicated by its commitment to the Science Based Targets initiative (SBTi). The company has committed to a net-zero target. Further details regarding specific reduction targets and the years for achieving them are currently being developed. The company's emissions data is not cascaded from a parent organisation.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Maravai LifeSciences’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Maravai LifeSciences yet.
Scope 3 top emissions categories
8 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Maravai LifeSciences’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project